|
|
The iQ&A interactive Medical Intelligence Zone is a needs assessment-driven continuing medical education (CME) activity that utilizes international experts to provide evidence-based, guideline-consistent, and practice behavior-changing information focused on critical and challenging topics in clinical medicine.
To ensure that the educational content of iQ&A programs will address practice gaps in clinical medicine, improve patient outcomes, and positively guide clinical practice strategies, international experts, usually in a roundtable format, will respond to questions submitted and/or generated by practitioners at CME mega-symposia, national congress, association meetings, or as part of on-line, enduring CME programs.
Questions reflecting the clinical needs of practitioners are then answered, analyzed, and discussed by international experts, who provide evidence-based and clinically relevant guidance that is independently of commercial sources or the program sponsor.
The iQ&A platform stresses:
Registration Participation in the iQ&A interactive Medical Intelligence Zone for Sepsis is complimentary, and clinicians are invited to participate in this CME-certified program and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals. Grantor Support Supported by an independent educational grant from Eisai, Inc.  Accreditation Statement This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the The University of Massachusetts Medical School and CMEducation Resources, LLC. The The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians. Credit Designation Statement The The University of Massachusetts Medical School designates this educational activity for a maximum of 3.0 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity. Policy on Faculty & Provider Disclosure It is the policy of the The University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the The University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials. Program Faculty and Disclosure Steven M. Opal, MD Professor of Medicine The Warren Alpert School of Medicine of Brown University Chief, Infectious Disease Division, Memorial Hospital of Rhode Island Providence, RI Research Support: Inimex, Sirtris, Eisai, Atoxbio Prof. Dr. Mihai G. Netea Department of Medicine Radboud University Nijmegen Medical Center The Netherlands Nothing to disclose Derek C. Angus, MD, MPH, FRCP Chair, Department of Critical Care Medicine Professor of Critical Care Medicine, Medicine, Health Policy and Management, and Clinical and Translational Science University of Pittsburgh School of Medicine and Graduate School of Public Health Pittsburgh, PA Grant/Research Support: Eisai Principal Investigator: Long-Term Follow-Up, Multi-Center Sepsis Study (Grant Awarded to University of Pittsburgh) Member of DSMN, Eli Lilly Steven Lowry, MD Professor and Chairman Department of Surgery University of Medicine and Dentistry of New Jersey (UMDNJ) Robert Wood Johnson Medical School Senior Associate Dean for Education Nothing to disclose Prof. Jean-Louis Vincent, MD, PhD Professor, Intensive Care University of Brussels Head of the Department of Intensive Care Erasme University Hospital Brussels, Belgium Consultant: Eisai, Wyeth, Astellas, Artisan Pharmaceuticals, Eli Lilly, Novartis Speaker's Bureau: Eisai, GSK, Eli Lilly Charles A. Dinarello, MD Professor of Medicine University of Colorado School of Medicine Denver, CO Nothing to disclose Jean-Paul Mira, MD, PhD Professor of Critical Care Medicine Chair, Medical Intensive Care Unit Head, Variability of Innate Immunity Research Laboratory Cochin-St.Vincent dePaul University Hospital Paris, France Consultant: Eli Lilly; LFB; EISAI Advisory Boards: EISAI; LFB Honoraria: Eli Lilly, LFB, Novartis, MSD, BRAHMS Konrad Reinhart, MD, PhD Director Department of Anesthesiology and Intensive Care Medicine University Hospital of the Friedrich Schiller University of Jena Jena, Germany Consultant: SIRS-Lab Jena, E. Lilly, Edwards Life Sciences Advisory Boards: Esai Simon Finfer, MBBS, MRCP, FRCA Senior Staff Specialist Intensive Care Royal North Shore Hospital Sydney, Australia Consultant: Eli Lilly, Eisai (payment and fees go to the employer) Mark Tidswell, MD Assistant Professor of Medicine Tufts University School of Medicine Director, Critical Care Medicine Fellowship Program Director, Intermediate Care Unit Baystate Medical Center Springfield, MA Consultant: Eisai Medical Research, Inc. Grant/Research Support: Clinical research conducted for Eisai Medical Research, Inc., Altor Biosciences, Artisan Pharma, Pfizer, Ferring Pharmaceuticals Richard Wunderink, MD Professor of Medicine, Pulmonary and Critical Care Feinberg School of Medicine Northwestern University Chicago, IL Consultant: Novartis, Astra Zeneca, bioMerieux, Amgen Advisory Boards: Pfizer, Bayer, bioMerieux Research Support: Pfizer, Novartis, bioMerieux Michael A. Matthay, MD Professor of Medicine and Anesthesia University of California at San Francisco San Francisco, CA Nothing to disclose Tom van der Poll, MD Professor of Medicine Head Center for Experimental and Molecular Medicine Academic Medical Center Amsterdam, Netherlands Consultant: Eisai, Novartis Grant/Research Support: Eisai, Novartis, Eli Lilly, Sirtris, Crucell Educational Objectives Upon completion of this activity, participants will be able to:
Disclaimer Copyright © 2010 by Pharmatecture, LLC and CMEducation Resources, LLC All rights reserved. Reproduction, distribution, or translation without express written permission is strictly prohibited. Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity. Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations. Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman. Opinions expressed herein are not necessarily those of Pharmatecture, LLC, CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations. Copyright © CMEducation Resources, LLC and Pharmatecture, LLC
|
|
